ozono generavimo iš oro deguonies in situ naudojant bwt bewazon įrenginius sistema.
bwt holding gmbh, walter-simmer-straße 4, 5310, mondsee, austrija. - ozonas, gautas iš oro deguonies in situ. - veikliosios medžiagos cas nr.: -, eb nr.: -, veikliosios medžiagos pavadinimas: ozonas, gautas iš oro deguonies in situ., koncentracija: 5.3% , veiklioji
ozono generavimo iš oro deguonies in situ naudojant bwt steritron įrenginius sistema
bwt holding gmbh, walter-simmer-straße 4, 5310, mondsee, austrija. - ozonas, gautas iš oro deguonies in situ. - veikliosios medžiagos cas nr.: -, eb nr.: -, veikliosios medžiagos pavadinimas: ozonas, gautas iš oro deguonies in situ., koncentracija: 0.01% , veiklioji
lusopress
istituto luso farmaco d'italia s.p.a. - nitrendipinas - tabletės - 20 mg - nitrendipine
pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antinavikiniai vaistai - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.
propofol baxter
baxter holding b.v. - propofolis - injekcinė ar infuzinė emulsija - 20 mg/ml; 10 mg/ml - propofol
ciprofloxacin baxter [ciprofloxacin claris]
baxter holding b.v. - ciprofloksacinas - infuzinis tirpalas - 2 mg/ml - ciprofloxacin
dobutamine baxter
baxter holding b.v. - dobutaminas - koncentratas infuziniam tirpalui - 12,5 mg/ml - dobutamine
ondansetron baxter
baxter holding b.v. - ondansetronas - injekcinis tirpalas - 2 mg/ml - ondansetron
sevoflurane baxter
baxter s.a. - sevofluranas - įkvepiamieji garai (skystis) - 100 % - sevoflurane
fluconazole baxter
baxter holding b.v. - flukonazolas - infuzinis tirpalas - 2 mg/ml - fluconazole